Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexycu vs Standard of Care for Post-Cataract Inflammation and Pain
NCT04781335Phase 4Completed
- Sponsor
- Eye Institute of West Florida
- Start
- Feb 2020
- Primary completion
- Dec 2022
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of IBI-10090 in post-operative ocular inflammation, post-operative ocular pain, sponsored by Eye Institute of West Florida. Started Feb 2020; status: completed.
02
Drugs
IBI-10090
03
Conditions
post-operative ocular inflammationpost-operative ocular pain
Beyond the preview
Go deeper on NCT04781335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04781335.